443465002: Ustekinumab (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Interleukin receptor antagonist\Substance with interleukin 23 receptor antagonist mechanism of action (substance)\Ustekinumab (substance)
\Substance categorized by disposition\Immunomodulator\Interleukin receptor antagonist\Substance with interleukin 23 receptor antagonist mechanism of action (substance)\Ustekinumab (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Ustekinumab (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Ustekinumab (substance)

\Biological substance\Protein and/or protein derivative\Protein\Antibody\Monoclonal antibody\Ustekinumab (substance)
\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Ustekinumab (substance)
\Biological substance\Polypeptide\Protein\Antibody\Monoclonal antibody\Ustekinumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2010. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2835090011 Ustekinumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2842331014 Ustekinumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

54461000195110 ustekinumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

848581000172119 ustékinumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

68811000195111 Ustekinumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ustekinumab (substance)	Is a	agent d'anticorps monoclonal	false	Inferred relationship	Some
Ustekinumab (substance)	Is a	Monoclonal antibody	true	Inferred relationship	Some
Ustekinumab (substance)	Is a	Antineoplastic agent (substance)	true	Inferred relationship	Some
Ustekinumab (substance)	Is a	Substance with interleukin 23 receptor antagonist mechanism of action (substance)	true	Inferred relationship	Some
Ustekinumab (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Interleukin 23 receptor antagonist (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Ustekinumab 90mg/mL injection solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ustekinumab (substance)	Inferred relationship	Some
Product containing ustekinumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ustekinumab (substance)	Inferred relationship	Some	1
Ustekinumab therapy (procedure)	Direct substance	True	Ustekinumab (substance)	Inferred relationship	Some	2
Product containing only ustekinumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ustekinumab (substance)	Inferred relationship	Some	1
Ustekinumab 90 mg/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ustekinumab (substance)	Inferred relationship	Some	1
Ustekinumab 90 mg/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ustekinumab (substance)	Inferred relationship	Some	1
Product containing only ustekinumab in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ustekinumab (substance)	Inferred relationship	Some	1
Ustekinumab-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ustekinumab (substance)	Inferred relationship	Some	1

Reference Sets

Description inactivation indicator reference set